Variant report
Variant | nsv981891 |
---|---|
Chromosome Location | chr8:113901858-113903687 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs546755815 | chr8:113901875-113901876 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs566743507 | chr8:113901907-113901908 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs538940921 | chr8:113901919-113901920 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs559243913 | chr8:113901929-113901930 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs569156650 | chr8:113901950-113901951 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs538192396 | chr8:113901951-113901952 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs555013712 | chr8:113901988-113901989 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs143998281 | chr8:113902038-113902039 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
9 | rs75062115 | chr8:113902048-113902049 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
10 | rs553989435 | chr8:113902104-113902105 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
11 | rs577145479 | chr8:113902175-113902176 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
12 | rs545767936 | chr8:113902178-113902179 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
13 | rs562846557 | chr8:113902253-113902254 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs539200027 | chr8:113902256-113902257 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs183753685 | chr8:113902350-113902351 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs34013396 | chr8:113902386-113902387 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs541765940 | chr8:113902399-113902400 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs76223017 | chr8:113902410-113902411 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs527357518 | chr8:113902445-113902446 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs147312101 | chr8:113902470-113902471 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs557942287 | chr8:113902473-113902474 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs141014269 | chr8:113902485-113902486 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs572843480 | chr8:113902492-113902493 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs189314466 | chr8:113902493-113902494 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs540371181 | chr8:113902530-113902531 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs569493791 | chr8:113902561-113902562 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs538172787 | chr8:113902583-113902584 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs369748950 | chr8:113902599-113902600 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs561506725 | chr8:113902607-113902608 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs554977100 | chr8:113902620-113902621 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs573715520 | chr8:113902690-113902691 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs568497077 | chr8:113902720-113902721 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs142477184 | chr8:113902739-113902740 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs573812471 | chr8:113902793-113902794 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs554346364 | chr8:113902875-113902876 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs73346012 | chr8:113902881-113902882 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs182305334 | chr8:113902917-113902918 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs556090827 | chr8:113902936-113902937 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs544243968 | chr8:113902954-113902955 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs540665050 | chr8:113903009-113903010 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs144433758 | chr8:113903030-113903031 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs563945845 | chr8:113903098-113903099 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs11985714 | chr8:113903152-113903153 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
44 | rs575961393 | chr8:113903196-113903197 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs185647391 | chr8:113903226-113903227 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs561325088 | chr8:113903282-113903283 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs544586502 | chr8:113903309-113903310 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs571741578 | chr8:113903336-113903337 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs540725722 | chr8:113903380-113903381 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs35360881 | chr8:113903482-113903483 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Gastric cancer | 17908304 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Seminomas | 18059402 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 17603634 | CNVD |
Testicular cancer | 18059402 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 21509527 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Cancer | 20164919 | CNVD |
abnormal development | 18461090 | CNVD |
Oral cancer | 21386901 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Langer-Giedion syndrome | 22283845 | CNVD |
Cancer | 21637783 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 20632083 | CNVD |
Breast cancer | 19602461 | CNVD |
Cancer | 22429812 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oral cancer | 19627613 | CNVD |
Prostate cancer | 21088497 | CNVD |
colon cancer | 17210682 | CNVD |
Breast cancer | 21264507 | CNVD |
Breast cancer | 22028636 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 16751803 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Gastric cancer | 17167181 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Breast cancer | 16461572 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
head and neck squamous cell carcinoma | 18028549 | CNVD |
Breast cancer | 17001317 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 16608533 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Prostate cancer | 18632612 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Prostate cancer | 16573809 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Adenocarcinoma | 21044232 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Prostate cancer | 16461572 | CNVD |
Breast cancer | 21399628 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Breast cancer | 17393978 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Breast cancer | 17899364 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Autosomal-dominant progressive external ophthalmoplegia | 19664747 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Sezary syndrome | 18413736 | CNVD |
Breast cancer | 21611746 | CNVD |
Developmental delay | 21147756 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Congenital diaphragmatic hernia | 21525063 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Breast cancer | 21364760 | CNVD |
Neuroticism | 17667963 | CNVD |
Papillary thyroid cancer | 17515504 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Schizophrenia | 20967226 | CNVD |
Prostate cancer | 22341455 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
T-cell lymphomas | 22341440 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:113895400-113904800 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
2 | chr8:113896800-113905200 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
3 | chr8:113897000-113904800 | Weak transcription | iPS-20b Cell Line | embryonic stem cell |
4 | chr8:113897200-113904800 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |
5 | chr8:113897400-113905000 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
6 | chr8:113900200-113902600 | Enhancers | HMEC | breast |
7 | chr8:113900600-113902600 | Enhancers | NHEK | skin |
8 | chr8:113900800-113902600 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
9 | chr8:113900800-113906400 | Weak transcription | H9 Cell Line | embryonic stem cell |
10 | chr8:113901000-113902000 | Enhancers | Cortex derived primary cultured neurospheres | brain |
11 | chr8:113901200-113902600 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
12 | chr8:113901600-113902000 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
13 | chr8:113902000-113902200 | Flanking Active TSS | Foreskin Keratinocyte Primary Cells skin02 | Skin |
14 | chr8:113902200-113902600 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
15 | chr8:113903400-113903600 | Enhancers | Brain Germinal Matrix | brain |